Equities

Enlitic Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ENL:ASX

Enlitic Inc

Actions
TechnologyTechnology
  • Price (AUD)0.008
  • Today's Change-0.001 / -11.11%
  • Shares traded1.26m
  • 1 Year change-91.11%
  • Beta--
Data delayed at least 20 minutes, as of Mar 03 2026 04:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Enlitic, Inc. is a healthcare information technology (IT) company that uses Artificial Intelligence (AI) to expand capacity and improve clinical workflows and create a foundation for a real-world evidence medical image database for healthcare providers. It is focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Its products include ENDEX, ENCOG, ENCODE, and ENSIGHT. ENDEX transforms new and historical medical image data descriptions to a consistent, clinically relevant standard nomenclature that impacts workflows and capacity within and beyond radiology. ENCOG deidentifies and anonymizes imaging data to remove PHI from pixel data, metadata, and private tags while retaining clinically relevant information.

  • Revenue in AUD (TTM)4.01m
  • Net income in AUD-21.45m
  • Incorporated2014
  • Employees--
  • Location
    Enlitic Inc2510 East Harmony Rd., Suite 202FORT COLLINS 80528United StatesUSA
  • Phone+1 (302) 658-7581
  • Fax+1 (302) 655-5049
  • Websitehttps://www.enlitic.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.